Losartan fails to reduce lung injury in patients hospitalized with COVID-19 - Healio

Losartan failed to reduce lung injury or improve clinical outcomes in patients hospitalized with COVID-19, researchers reported in JAMA Network Open.“Even though this particular drug was not effective for the treatment of COVID-19, repurposing inexpensi…

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio Losartan failed to reduce lung injury or… [+3528 chars]

full article...